Shandong Tumor Hospital
Clinical trials sponsored by Shandong Tumor Hospital, explained in plain language.
-
New hope for stomach cancer: drug combo targets tough cases
Disease control Recruiting nowThis study tests a combination of two drugs (carilizumab and albumin paclitaxel) as a second treatment for people with advanced stomach cancer. It includes 40 adults who have already tried one prior treatment, with or without immunotherapy. The goal is to see if the combo can slo…
Phase: PHASE2 • Sponsor: Shandong Tumor Hospital • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New hope for stomach cancer patients: triple-drug combo tested in clinical trial
Disease control Recruiting nowThis study tests whether a combination of three drugs (adebrelimab, famitinib, and irinotecan) works better than irinotecan alone for people with advanced stomach cancer whose first treatment has stopped working. About 66 participants will be randomly assigned to one of the two g…
Phase: PHASE2 • Sponsor: Shandong Tumor Hospital • Aim: Disease control
Last updated May 13, 2026 15:58 UTC